Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Areas with lower population density have not seen the same slowdown as urban areas.
Optimal treatment for fatty liver disease may involve combining drugs with different mechanisms of action.
New report highlights cancer’s toll on racial and ethnic minorities and other underserved populations.
Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.
October is Liver Cancer Awareness Month.
Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.
NAFLD is the leading indicator of mortality among Medicare beneficiaries with hepatocellular carcinoma.
Hepatitis A and B can be prevented with vaccines, and hepatitis C can be cured with antiviral treatment.
The Supreme Court justice, who is undergoing biweekly chemotherapy, says she remains fully able to carry out her work on the court.
Some experts have doubted the link between sustained virologic response and clinical outcomes.
Transplants due to hepatitis C have declined dramatically thanks to effective treatment.
Those with fatty liver disease and cirrhosis should undergo regular screening.
This finding from a large study surprised and concerned researchers.
Cancer mortality fell by 29% between 1991 and 2017, largely driven by a decline in lung cancer deaths.
Three fatty liver disease candidates miss the mark for effectiveness or safety.
Smoking cessation, moderate drinking, a healthy diet, exercise and weight loss could dramatically reduce the growing burden of liver cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.